‘Viral fusion’ fuels extra-potent vaccine for RSV, could be deployed for flu, researchers say
By
Aaron Dorman
Mar 19, 2024
A new “3D vaxlock” process creates a vaccine 11 times more potent than “standard industry comparators,” new research shows.
For the first time, vaccines are available for all 3 viruses targeting older adults
By
Kimberly Bonvissuto
Sep 20, 2023
COVID-19 and respiratory syncytial virus cases are increasing, and the height of influenza season is on the horizon, but older adults and long-term care staff members are entering the first virus season...